GlassScriptPhysician profile
Morgan L Campbell
NPI 1497011431
$7,063.48
in general payments reported to CMS, 2019-2025
56 companies · $1,180 in 2025
The $1,180 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $446 · 2021: $875 · 2022: $1,122 · 2023: $1,593 · 2024: $1,400 · 2025: $1,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,173.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,366.99 | 2021-2025 | Vraylar, Liletta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $798.65 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $437.26 | 2019-2025 | |
| Lilly USA, LLC | $428.70 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Vanda Pharmaceuticals INC. | $317.66 | 2020-2023 | Hetlioz, Fanapt |
| Novo Nordisk INC | $309.51 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $298.81 | 2019-2025 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.38 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $243.72 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Novartis Pharmaceuticals Corporation | $213.10 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $190.52 | 2021-2025 | |
| Abbott Laboratories | $176.86 | 2021-2024 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Astellas Pharma US INC | $162.10 | 2020-2025 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $133.32 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.79 | 2020-2025 | Xifaxan, Trulance |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $116.99 | 2020-2023 | Austedo Xr, Austedo |
| Sanofi Pasteur INC. | $108.69 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $95.09 | 2019-2025 | Capvaxive, Vaxneuvance, Gardasil 9 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $74.74 | 2022-2025 | Caplyta |
| Exact Sciences Corporation | $67.30 | 2023-2024 | Cologuard Collection Kit |
| Insightec,INC | $62.87 | 2023 | Exablate |
| Janssen Pharmaceuticals, INC | $61.67 | 2019-2024 | Spravato |
| Dexcom, INC. | $61.37 | 2023-2025 | Dexcom G6 Transmitter |
| Grifols USA, LLC | $58.86 | 2019-2023 | Prolastin-C Liquid |
| Amarin Pharma, INC. | $57.11 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $56.43 | 2021-2022 | |
| Gilead Sciences, INC. | $56.02 | 2019-2020 | |
| Seqirus USA INC | $54.43 | 2022-2025 | Flucelvax, Fluad |
| Allergan, INC. | $49.95 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $43.90 | 2024 | Gemtesa |
| Edwards Lifesciences Corporation | $42.84 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Hologic Sales and Service, LLC | $40.14 | 2020-2024 | Aptima |
| Intuitive Surgical, INC. | $40.05 | 2025 | |
| Lucid Diagnostics INC. | $36.51 | 2022-2024 | |
| Alkermes, INC. | $32.89 | 2021-2022 | |
| Cranial Technologies, INC | $31.22 | 2021-2025 | Doc Band |
| Baxter Healthcare | $27.08 | 2022 | |
| Esperion Therapeutics, INC. | $22.36 | 2021 | |
| Eisai INC. | $21.69 | 2021 | |
| Inspire Medical Systems, INC. | $21.59 | 2023 | Inspire |
| Aimmune Therapeutics, INC. | $20.58 | 2025 | Zenpep |
| Organon LLC | $18.50 | 2025 | Nexplanon |
| Corium, LLC | $18.01 | 2023 | Azstarys |
| Bausch Health US, LLC | $17.48 | 2020 | |
| Indivior INC. | $15.50 | 2024 | Sublocade |
| Philips North America LLC | $15.48 | 2024 | (Ck7) Extended Holter |
| Otsuka America Pharmaceutical, INC. | $14.89 | 2024 | Rexulti |
| Medtronic Minimed, INC. | $14.75 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.71 | 2023 | Vpriv |
| Ultragenyx Pharmaceutical INC. | $14.68 | 2019 | |
| Daiichi Sankyo INC. | $14.63 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.40 | 2023 | Dupixent |
| Lundbeck LLC | $13.48 | 2022 | |
| Sunovion Pharmaceuticals INC. | $12.58 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.23 | 2021 | |
| Ossur Americas, INC. | $9.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.